Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis Korean Patients: a Multicenter Post-marketing Observational Study

NCT03535649 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03535649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis Korean Patients: a Multicenter Post-marketing Observational Study
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
August 17, 2017
Completion date
December 18, 2018
Enrollment
105 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, ulcerative